158 related articles for article (PubMed ID: 22408448)
1. A novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factor.
Mao Y; Zhang DW; Wen J; Cao Q; Chen RJ; Zhu J; Feng ZQ
Int J Mol Sci; 2012; 13(2):2208-2218. PubMed ID: 22408448
[TBL] [Abstract][Full Text] [Related]
2. A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.
Chen R; Zhang D; Mao Y; Zhu J; Ming H; Wen J; Ma J; Cao Q; Lin H; Tang Q; Liang J; Feng Z
Mol Cancer Ther; 2012 Mar; 11(3):594-603. PubMed ID: 22169768
[TBL] [Abstract][Full Text] [Related]
3. Synergistic action of Hedyotis diffusa Willd and Andrographis paniculata in Nasopharyngeal Carcinoma: Downregulating AKT1 and upregulating VEGFA to curb tumorigenesis.
Ye C; Zhang B; Tang Z; Zheng C; Wang Q; Tong X
Int Immunopharmacol; 2024 May; 132():111866. PubMed ID: 38603854
[TBL] [Abstract][Full Text] [Related]
4. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
[TBL] [Abstract][Full Text] [Related]
5. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
6. EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model.
Ke X; Yang YC; Hong SL
Med Oncol; 2011 Dec; 28 Suppl 1():S326-32. PubMed ID: 20862567
[TBL] [Abstract][Full Text] [Related]
7. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
Chang PY; Wu ZZ; Sun NK; Chao CC
J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
[TBL] [Abstract][Full Text] [Related]
8. Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism.
Zhang W; Kang M; Zhang T; Li B; Liao X; Wang R
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999372
[TBL] [Abstract][Full Text] [Related]
9. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
[TBL] [Abstract][Full Text] [Related]
10. Limb-bud and Heart (LBH) functions as a tumor suppressor of nasopharyngeal carcinoma by inducing G1/S cell cycle arrest.
Liu Q; Guan X; Lv J; Li X; Wang Y; Li L
Sci Rep; 2015 Jan; 5():7626. PubMed ID: 25557837
[TBL] [Abstract][Full Text] [Related]
11. Laminaria Japonica Polysaccharides effectively inhibited the growth of nasopharyngeal carcinoma cells in vivo and in vitro study.
Zeng M; Wu X; Li F; She W; Zhou L; Pi B; Xu Z; Huang X
Exp Toxicol Pathol; 2017 Sep; 69(7):527-532. PubMed ID: 28501488
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine synergizes with cisplatin to inhibit nasopharyngeal carcinoma cell proliferation and tumor growth.
He SW; Zhang Y; Chen L; Luo WJ; Li XM; Chen Y; Huang SY; He QM; Yang XJ; Li YQ; Liu N; Zhao Y; Ma J
FASEB J; 2021 Oct; 35(10):e21885. PubMed ID: 34478585
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
[TBL] [Abstract][Full Text] [Related]
14. A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.
Wu Y; Tang M; Wu Y; Weng X; Yang L; Xu W; Yi W; Gao J; Bode AM; Dong Z; Cao Y
Cell Oncol (Dordr); 2014 Feb; 37(1):53-67. PubMed ID: 24306928
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.
Matsumoto K; Konno H; Tanaka T; Baba M; Kanai T; Kamiya K; Ohba K; Nakamura S
Jpn J Cancer Res; 2000 Jul; 91(7):748-52. PubMed ID: 10920283
[TBL] [Abstract][Full Text] [Related]
16. Targeting EZH2 depletes LMP1-induced activated regulatory T cells enhancing antitumor immunity in nasopharyngeal carcinoma.
Sun W; Chen L; Tang J; Zhang C; Wen Y; Wen W
J Cancer Res Ther; 2020; 16(2):309-319. PubMed ID: 32474518
[TBL] [Abstract][Full Text] [Related]
17. Clusterin induced by N,N'-Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis.
Li Y; Lu J; Zhou S; Wang W; Tan G; Zhang Z; Dong Z; Kang T; Tang F
Oncotarget; 2016 Feb; 7(5):5548-63. PubMed ID: 26716898
[TBL] [Abstract][Full Text] [Related]
18. Arenobufagin induces cell apoptosis by modulating the cell cycle regulator claspin and the JNK pathway in nasopharyngeal carcinoma cells.
Ho HY; Chen MK; Lin CC; Lo YS; Chuang YC; Hsieh MJ
Expert Opin Ther Targets; 2024 May; 28(5):461-471. PubMed ID: 38659296
[TBL] [Abstract][Full Text] [Related]
19. EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.
Yang L; Liu L; Xu Z; Liao W; Feng D; Dong X; Xu S; Xiao L; Lu J; Luo X; Tang M; Bode AM; Dong Z; Sun L; Cao Y
Oncotarget; 2015 Mar; 6(8):5804-17. PubMed ID: 25714020
[TBL] [Abstract][Full Text] [Related]
20. Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma.
Liu J; Zhang Y; Sun P; Xie Y; Xiang J; Yang J
Oncol Rep; 2013 Sep; 30(3):1165-74. PubMed ID: 23783436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
